Thailand - Delayed Quote THB

Bumrungrad Hospital Public Company Limited (BH.BK)

166.00
-3.00
(-1.78%)
At close: April 24 at 4:39:13 PM GMT+7

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in THB.
NameTitlePayExercisedYear Born
Ms. Linda Lisahapanya President, MD & Executive Director 1.79M -- 1953
Ms. Artirat Charukitpipat Ph.D. Chief Executive Officer -- -- 1968
Ms. Oraphan Buamuang CPA Chief Financial Officer -- -- 1974
Dr. Nipat Kulabkaw Chief Operating Officer -- -- --
Ms. Supawan Sirinuntawit Accounting Manager -- -- --
Dr. Polakit Teekakirikul M.D. Chief Science Officer -- -- --
Mr. Daniel Kastner Chief Transformation Office & Head of IR -- -- --
Dr. Aniello M. Sorrentino Ph.D. Corporate Chief Strategy Officer -- -- 1948
Mr. David T. Boucher FACHE, M.P.H. Chief Business Transformation Officer -- -- --
Tanee Maneenut Chief Business Development Officer -- -- --

Bumrungrad Hospital Public Company Limited

33 Sukhumvit Soi 3 (Nana Nua)
Sukhumvit Road Klongtoey Nua Sub District Wattana Distric
Bangkok, 10110
Thailand
66 2 066 8888 https://www.bumrungrad.com
Sector: 
Healthcare

Description

Bumrungrad Hospital Public Company Limited owns and operates hospitals in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, paediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Further, the company offers clinical research, hospital consulting and management, healthcare personnel development and training, healthcare referral, and digital platform services. Additionally, it is involved in the distribution of pharmaceutical and medical goods in specialized stores; development of software for healthcare services; holding of real estate assets; and manufacture and sale of vitamin supplements. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.

Corporate Governance

Bumrungrad Hospital Public Company Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 24, 2025 at 10:59 AM UTC

Bumrungrad Hospital Public Company Limited Earnings Date

Recent Events

April 16, 2025 at 12:00 AM UTC

F-6EF: Offering Registrations

March 19, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers